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Summary
In the preceding period, correlations between the steric positions
of the amino groups of dianilines and the microbial mutagenicity
of a series of these compounds were investigated using the Ames
Salmonella assay. The effects of phenyl ring coupling moieties,
of the isomeric positions of the amino groups relative to the
coupling groups, and of insertion of other coupling groups on the
mutagenic response of these compounds were also investigated. In
most cases, S-9 metabolic activation from Aroclor-induced rat
liver was required for mutagenic expression. The range of muta-
genicity of steric isomers of several dianiline compounds was also
investigated. No mutagenicity was found for purified samples of
o,o' and m,p' isomers of methylene dianiline (MDA) and diaminobenzo-
phenone (DABP), while varied degrees of mutagenicity were found
for the other isomers. The mutagenicity of "benzylogs" of MDA
decreased as the degree of linear separation of the m,m' anilino
groups by aromatic rings increased. Additional work, described
in this report, showed that methylation and long-term (two-year)
storage increased mutagenic response in certain isomers of meth-
ylene dianiline. However, high performance liquid chromatography
indicated that there was no discernible change in m,p'-MDA samples
aged under varied conditions during a four-month aging study.
Likewise, no change in mutagenicity was found. Retesting of p,p'
and m,m' MDA isomers by the Ames assay previously tested in 1979,
gave similar results for the p,p' isomer but lower mutagenicity
for the m,m' isomer.
Bioactivity mechanisms are obscured by the fact that metabolic
activation is required for an expression of mutagenicity by the
bioactive isomers. This indicates the ultimate mutagenic com-
pounds are as yet unidentified metabolic products of the original
isomers after treatment with S-9 fractions from Aroclor-induced
rat liver.
In vitro cytoxicity assays indicate similar and moderate-to-low-
acute toxicity for the DABP isomers. There appears to be no cor-
relation between acute toxicity and mutagenicity.
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INTRODUCTION
Aromatic amines are widely used in the preparation and use of
high performance polyamides and polyimides. They are used in
even larger quantities as curing agents for polyurethanes and
epoxies. Certain aromatic amines have been suspected as human
carcinogens (Selkirk, 1980) and certain ones have been shown to
be mutagenic agents in animals; e.g., benzidine (Windholz, 1976;
Lewis, 1980). Consequently, the aromatic amines as a class are
receiving scrutiny to determine just how general this mutagenic
behavior is. At the present time, there is no generally accepted
theory that would explain the mechanism responsible for the muta-
genic nature of aromatic amines.
Polymer chemists in the Materials Division of NASA's Langley
Research Center have been synthesizing new and relatively rare
aromatic diamines for use in thermally stable polymers for a dozen
years. During this time, many different aromatic diamines have
been synthesized. Only a very few of these have ever been com-
mercially available. The preparation of these diamines was the
result of the philosophy that useful and predictable chemical,
physical, and mechanical properties could be tailored into the
polymers if the chemicals used as starting materials contained the
proper structural features. If a certain chemical feature is to
be contained in a polymer, it is much easier to insert it into the
polymer via the monomer than it is to modify the polymer itself.
Because of the very specific and systematic variations in the
chemical structures of the diamines, significant differences in
the properties of the resulting polymers were achieved. These
differences, such as lower initial softening points leading to
improved processability, higher final melting points and thus
higher use temperatures, and better adhesive strengths, were then
directly attributable to the precise variations in the diamine
monomers.
1
The diamines used in the polymer studies thus represent a unique
collection of valuable chemicals which could be used as the basis
of an investigation into the steric, chemical, and electronic
features occurring in aromatic diamines which cause certain ones
to be potential carcinogens.
Preliminary testing done in this study using the Ames microbial
mutagenicity assay (Ames et al., 1975) indicated that there was a
relationship between the isomeric positions of the amine group on
the diphenylmethane moiety and the mutagenicities of the diamine
isomers. Therefore, an extensive study was designed to evaluate
a series of aromatic diamine compounds and their corresponding
steric isomers in order to gain insight into possible explana-
tions for mechanisms of mutagenicity by the most widely accepted
in vitro mutagenicity assay, the Ames Salmonella test procedure.
The Ames mutagenicity data from the entire study are summarized
in a manuscript found in Appendix A of this report and in a Final
Report dated April 1982. The manuscript will be submitted to the
journal, "Environmental Mutagenesis."
Supplemental funds were added to this contract in 1982 for addi-
tional studies of amine degradation and oxidation products, the
mechanisms of amine bioactivity, the acute toxicity of diamino-
benzophenone isomers, and retesting of m,m'-MDA and p,p'-MI)A to
resolve inconclusive Ames bacteria assay data. This report covers
data resulting from completion of each of the above tasks and
resummarizes Ames data obtained from previous investigations.
AMINE DEGRADATION/OXIDATION PRODUCTS
The objective of this portion of the study was to identify and
approximate the quantities of any products resulting from the
aging of m,p'-diaminodiphenylmethane (m,p'-MDA). The aged sam-
ples were compared with a relatively pure sample of this isomer
[m,p'-MDA-F-2(484)] submitted earlier in this investigation and
shown to have low mutagenicity by the Ames test. These samples
were treated by the NASA Technical Project Officer to simulate
aging under several environmental conditions. Sample m,p'-MDA-AI
(498) was aged in an inert atmosphere at ambient room temperature.
Sample m,p'-MDA-A,A,RT (499) was aged in air at ambient room tem-
perature, and sample m,p'-MDA-A,A,50 (500) was aged in air at 50°C.
High Pressure Chromatography - High pressure liquid chromatography
(HPLC) was performed on these samples. The first set of instrument
conditions used in this study was as follows:
Instrument: Du Pont 8800 series
Detector: Schoeffel SF 770 OV/VIS, 254 mm
Temperature: ambient
Column: Du Pont Zorbax C8, 15 cm x 4.6 mm
Pre-column: Brownlee Spheri-5 C 8, 3 cm x 4 mm
Mobile phase gradient: 75_ methanol to i00_ methanol at
linear rate for ten minutes then
hold at i00_ for 30 min.
Flow rate: 1.5 mL/min.
Using these conditions, the chromatograms shown in Figure 1 (A-D)
were obtained. No significant differences among the samples are
observed. However, several relatively small impurity peaks can be
seen in each sample.
The samples were also analyzed using the same instrument conditions
but a different solvent composition to determine more ideal separa-
tion conditions. The second solvent composition used was 60_ iso-
octane, and 40_ methanol/methylene chloride at 1 mL/min flow rate.
Figure 2 (A-D) shows the four samples analyzed using the different
solvent. Again, no significant differences are noted among these
four samples even though the chromatograms are different from
those obtained with the instrument conditions described earlier.
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Although the minor peaks appear to be small relative to the major
MDA peak, no quantitative value can be obtained from the chromato-
gram because the wavelength for maximum sensitivity of each com-
ponent is unknown.
Analxsis for Nitrosamines - The four samples were also analyzed by
HPLC using the Thermoelectron TEA detector, which is a specific
detector for nitrosamines. No evidence of any nitrosamine compounds
was found in any of the four samples.
Comparison of Mutagenicity - These four samples were assayed for
mutagenicity (see Figures 14 and 15 in Appendix A). Minimal or
no mutagenicity was found for the samples tested. No significant
increase in mutagenicity was found among the samples aged under
different conditions, supporting the similarity of chromatograms
found by the HPLC analyses.
Because of the very small amounts of impurities in these samples,
not enough material corresponding to these extraneous peaks could
be recovered for identification.
Even though the samples aged in air (499, 500) had a red-brown
color while the samples stored in an inert atmosphere were near
white in color, no differences in composition as determined by
HPLC or by the mutagenicity assay were detected. The aging time
may not have been long enough. Previously, changes were noted
after two years (1977-1979) of storage time of the m,p'-MDA
(see Figure 13 in Appendix A).
MECHANISMS OF AMINE BIOACTIVITY
An ultimate and desirable goal of this research was to correlate
chemical structure with the mutagenic potency of the aromatic
diamines tested. Ideally, these compounds could provide a model
for the prediction of mutagenicity by chemical structure.
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The empirical data recovered from these studies show a rather
dramatic difference in the mutagenic potency as determined by the
Ames test system of different steric isomers in several related
compounds, ranging from no mutagenic activity to highly mutagenic
responses.
However, the requirement for metabolic activation indicates that
an unknown compound or compounds is involved in the mutagenic
behavior. Until these ultimate compounds are recovered and iden-
tified, it is very unlikely that a correlation of structure and
bioactivity can be established.
This conclusion was concurred by the following academic and
Monsanto authorities:
Dr. James Pyle - Professor Chemistry and Director of Graduate
Research at Miami University
Dr. Joseph Cantrell - Professor of Chemistry, Miami University
Dr. George Kantor - Professor of Molecular Biology, Wright
State University
Dr. D. Gerald Glasgow - Senior Research Specialist, Monsanto
Research Corporation
Mr. George A. Richardson - Senior Research Chemist (organic
synthesis), Monsanto Research
Corporation.
Dr. George Kantor, consultant for MRC in in vitro mutagenesis
testing, wrote the summary of structure/activity discussions pre-
sented in Appendix B.
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ACUTE TOX IC ITY OF D IAM INOBENZOPHENONE (DABP) ISOMERS
The six steric isomers of diaminobenzophenone (DABP) were assayed
for acute cytotoxicity by the mammalian cell clonal test. This
study was performed to determine if there is correlation between
in vitro acute toxicity and in vitro mutagenicity of DABP isomers,
another possible key to insight into mutagenicity mechanisms. The
rationale was that some compounds that exhibit acute toxicity
affect the DNA synthesis or S phase of the cell replication cycle.
If incorporation of such compounds in nuclear material occurs, we
would expect that steric isomers that are mutagenic would also
show toxicity and that the nonmutagenic isomers would be nontoxic.
The data shown in Table I indicate that all isomers of DABP are
moderate or low and very similar in toxicity. Therefore, muta-
genicity and toxicity appear not to be correlatable.
RETEST OF m,m'- AND p,p'-MDA IN AMES TEST
Ames bacterial tests initially made on m,m'-MDA and p,p'-MDA
using TA98 and TAI00 Salmonella strains resulted in data that
were statistically inconclusive according to the same computer-
ized statistical program used in the first study under this con-
tract. For this reason a decision was made to retest these two
isomers in hopes of obtaining more conclusive results.
For the preparation of the manuscript of Appendix A, the data ob-
tained from the Ames test of all the isomers of all the compounds
were displayed graphically, plotting revertants of bacterial
organisms per plate versus the dose of compound per plate. These
graphs are Figures 2-14 in Appendix A. The plots were made so
that all data could be more readily compared.
If the two-times-solvent-control background criteria used in the
EPA criterion for revertants/plate vs. g/plate is used with the
recovered data for the two isomers, moderate mutagenicity is
I0
TABLE I. MAMMALIANCELL CLONAL ASSAY FOR
ACUTE TOXICITY OF DABP ISOMERS
DABP ECs0, g/mL
isomer CHO-KI (hamster) D98S (human)
m,m' 2 x 10 -4 1 x 10-4
o,p' 7.5 x I0 -5- 2.5 x I0-§
o,o' 7.5 x I0 -s 7.5 x I0-§
p,p' 2.0 x 10 -4 6.0 x i0-§
m,p' 2.0 x 10 -4 1.0 x 10 -4
o,m' 1.0 x 10 -4 7.0 x i0-§
DMSO 100K survival I00_ survival
EPA toxicity
rating*
Low
Moderate
Moderate
Low, moderate
Moderate
Low, moderate
m_
Low: 1 x 10 -4 g/mL to 1 x 10 -3 g/mL
Moderate: 1 x I0-_ g/mL to 1 x 10 -4
High: <i x i0-_ g/mL.
g/mL
detected for both m,m'-MDA and the p,p'-MDA. However, to fulfill
the requirements of this Task, these two isomers were retested.
Table II lists the retest data and Figures 3 and 4 graphically
display the retest data of 1983 and tests performed in 1979.
Samples of these two isomers of MDA were stored from 1979 to
1983 in the dark and under refrigerator conditions but not in an
inert atmosphere. The p,p' MDA samples are quite similar both
in numbers of revertants and curve slopes for both strains. The
m,m' MDA isomer in the retest (1983) study, produced lower num-
bers of revertants than the 1979 test in both strains. However,
observing the graphs of both data sets there is good correlation
between the 1979 and 1983 data.
ii
TABLE II. RETEST DATA FOR m,m' MDA AND p,p' MDA
Strain
Isomer TA98 TAI00
m,m' MDA (1979)
m,m' MDA (1983)
p,p' MDA (1979)
p,p' MDA (1983)
Moderate
Low
Moderate
Moderate
Moderate
ND*
Moderate
Moderate
No detectable mutagenicity.
12
Retest data of p,p' MDA
0
100
_' • TA 98 1979
L,.
o TA 98 1983
0 l J 4 J J J J J I J I ,l i
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28
DOSE,pg/plate (XIO0)
A
B
A - 2_ solvent control of TAI00 (1979)
B - 2_ solvent control of TAI00 (1983)
C - 2_ solvent control of TA98 (1979)
D - 2X solvent control of TA98 (1983)
Figure 3. Original (1979) and retest data (1983) of
p,p'-MDA tested in Ames strains TA98 and TAI00.
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Figure 4. Original (1979) and retest data (1983) of
m,m'-MDA tested in Ames strains TA98 and TAI00.
14
APPENDIX A
MANUSCRIPT
_-_
PREFACE
The Ames data reported in Tables 3 through 6 of the Final Report
issued in April 1982, were summations of the results of computer-
ized statistical treatment procedures for objective and nonbiased
assessment of test results designed for Monsanto Company products.
Retests were performed when data were inconclusive. Sometimes
the retest data were also inconclusive. In preparing the data
for a manuscript it was observed other authors of work published
in the journal "Environmental Mutagenesis", where we intend to
submit the manuscript, comprising this Appendix, presented their
data in graphic and/or tabular form in terms of number of rever-
tants per plate versus quantity/plate. The graphic presentation
also seemed appropriate for our work, so this method was chosen
for the latest draft of our manuscript. The criterion applied
for calling a compound "mutagenic" or "no mutagenicity detected"
was adopted from "Level 1 Biological Testing Assessment and Data
Formatting," EPA 600/7-80-079, paragraph 4b, page 30:
If the solvent control value is within the normal range, a
chemical that produces a positive dose response over three
concentrations with the highest increase equal to twice the
solvent control value for TAI00 and two to three times the
solvent control value for strain TA98 is considered to be
mutagenic. For these strains, the dose-response increase
should start at approximately the solvent control value.
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IN VITRO MUTAGENICITY OF STERIC ISOMERS OF
AROMATIC DIAMINE COMPOUNDS
William D. Ross, Janet E. Spillman,
JoAnn Gridley, and Vernon L. Bell
Monsanto Research Corporation
Dayton Laboratory
Dayton, Ohio (W.D.R., J.E.S., J.A.G.)
Dayton, Ohio 45407
and
National Aeronautics and Space Administration
Langley Research Center
Hampton, Virginia (V.L.B.)
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ABSTRACT
Correlations between the steric positions of the amino groups of
dianilines and the microbial mutagenicity of a series of these
compounds were investigated using the Ames Salmonella assay. The
effects of phenyl ring coupling moieties, of the isomeric posi-
tions of the amino groups relative to the coupling groups, and of
insertion of other coupling groups on the mutagenic response of
these compounds were also investigated. In most cases, S-9 acti-
vation from Aroclor-induced rat liver was required for mutagenic
expression. The range of mutagenicity of steric isomers of several
dianiline compounds was also investigated. No mutagenicity was
found for o,o' and m,p' isomers of methylene dianiline (MDA) and
diaminobenzophenone (DABP), while varied degrees of mutagenicity
were found for the other isomers. The mutagenicity of "benzylogs"
of MDA decreased as the degree of linear separation of the m,m'
anilino groups by aromatic rings increased. Methylation and long-
term (two-year) storage increased mutagenic response in certain
isomers of methylene dianiline.
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_O_S
In vitro mutagenicity, aromatic amines, dianilines, biphenyl
diamines, anilino steric isomers.
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INTRODUCTION
Aromatic amines are widely used in the preparation and use of
high performance polyamides and polyimides. They are used in
even larger quantities as curing agents for polyurethanes and
epoxies. Certain aromatic amines have been suspect human car-
cinogens (Selkirk, 1980) and certain ones have been shown to be
mutagenic agents in animals; e.g., benzidine (Windholz, 1976;
Lewis, 1980). Consequently, the aromatic amines as a class are
receiving scrutiny to determine just how general this mutagenic
amine behavior is. At the present time, there is no generally
accepted theory that would explain the mechanism responsible for
the mutagenic nature of aromatic amines.
Polymer chemists in the Materials Division of NASA's Langley
Research Center have been synthesizing new and relatively rare
aromatic diamines for use in thermally stable polymers for a
dozen years. During this time, many different aromatic diamines
have been synthesized. Only a very few of these have ever been
commercially available. The preparation of these diamines was
the result of the philosophy that useful and predictable chemical,
physical, and mechanical properties could be tailored into the
polymers if the chemicals used as starting materials contained
the proper structural features. If a certain chemical feature is
to be contained in a polymer, it is much easier to insert it into
the polymer via the monomer than it is to modify the polymer itself.
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Because of the very specific and systematic variations in the
chemical structures of the diamines, significant differences in
the properties of the resulting polymers were achieved. These
differences, such as lower initial softening points leading to
improved processability, higher final melting points and thus
higher use temperatures, and better adhesive strengths, were then
directly attributable to the precise variations in the diamine
monomers.
The diamines used in the polymer studies thus represent a unique
collection of valuable chemicals which could be used as the basis
of an investigation into the steric, chemical, and electronic
features occurring in aromatic diamines which cause certain ones
to be potential carcinogens.
Preliminary testing of this study using the Ames microbial muta-
genicity assay (Ames et al., 1975) indicated that there was a
relationship between the isomeric positions of the amine group on
the diphenylmethane moiety and the mutagenicities of the diamine
isomers. Therefore, an extensive study was designed to evaluate
a series of aromatic diamine compounds and their corresponding
steric isomers in order to gain insight into possible explanations
for mechanisms of mutagenicity by the most widely accepted i__nn
vitro assay, the Ames Salmonella mutagenicity assay.
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The specific objectives of this project were to:
Investigate the relative mutagenicity among some or all of
the six possible steric isomers of four series of dianiline
compounds, namely, methylene dianiline (MDA), diaminobenzo-
phenone (DABP), oxydianiline (ODA), and diaminodiphenyl
sulfone (DDS) (see Tables I and II for structures).
Assess relative mutagenicities among like isomers of the
above series of dianiline compounds.
Study the effects of the coupling moieties with a similar
steric isomer (o,m'), of aromatic diamines, MDA, DABP, ODA,
and DDS on mutagenicity.
Investigate the effects of proximity of the two anilino
groups on mutagenicity by evaluating methylene dianiline
(MDA) with "benzylogs" of m,m'-MDA: ml,m3-terbenzyl-P2
(m,ms-TBz) and m,,ms-quaterbenzyl-p2, P3 (m,m4-QBz) (see
Table I).
Investigate the effects of insertion of methyl groups in
steric isomers on the mutagenicity of MDA (Table I).
• Study the effects of sample aging and storage on mutagenicity.
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MATERIALS AND HANDLING METHODS
Materials
The test compounds were synthesized or otherwise obtained by
Dr. Vernon Bell (NASA-Langley Research Center) and checked for
purity by high pressure liquid chromatography (HPLC) and differ-
ential thermal analysis (DTA) procedures. In order to assure an
extended shelf-life, the samples were stored in a refrigerator at
I-9°C, with a nitrogen head space over the materials and shielded
from light.
Mutagenicity Assay
The microbial assay procedure was in general patterned after Ames
et al. [1975] using histidine-dependent Salmonella typhimurium
tester strains obtained from Dr. Ames' laboratory at the Univer-
sity of California, Berkeley. In this plate incorporation assay,
strains were used to detect both frameshift and base pair substi-
tution mutations. Tests were performed with and without* meta-
bolic activation using Aroclor-induced rat liver S-9 fractions
purchased from AMC Cancer Research Center, Lakewood, Colorado,
and Litton Bionetics, Kensington, Maryland.
*Initial tests indicated that the aromatic amines tested required
S-9 activation; therefore, follow-on tests were performed with
activation.
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Positive and negative controls were assayed with each compound
tested. The numbers of spontaneous revertants per plate of the
controls were compared with the laboratory's historical averages
to determine if they were within a statistically acceptable range.
The tester strains were Salmonella typhimurium histidine-dependent
mutants, TA98, TAI00, TA1535, TA1537, and TA1538.* These strains
were verified for genetic consistency on a routine basis by pheno-
typic determinations of histidine and biotin auxotrophy, crystal
violet sensitivity, ultraviolet light sensitivity, ampicillin
sensitivity, and spontaneous reversion frequency as recommended
by Ames et al. [1975]. Toxicity testing was performed to deter-
mine if test sample concentration ranges of i0, 3, I, 0.2, 0.04,
0.01 mg/plate** could be used. Triplicate culture plates were
used at all test sample concentrations and revertant colonies
counted using an Artek Model 880 automatic colony counter. The
sample solvent used in this study was dimethylsulfoxide (DMSO).
*In early studies, four and in some cases five tester strains
were used. Later protocols used only TA98 and TAI00; i.e.,
frameshift and base pair substitution mutation indicators.
**Early studies used a more narrow range; i.e., 0.01-2 mg/plate.
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Evaluation Criteria
Although all data were processed using a computerized statistical
treatment developed within Monsanto, we have elected to present
the data graphically plotting revertants versus concentration
(Figures 1-15) and then to summarize the data in Tables III-VII
by the criteria of Brusick [1980]. The Ames data were evaluated
as having either a positive effect or no mutagenicity detected
(ND). The level of activity was defined by the lowest concentra-
tion of the test sample at which mutagenicity could be detected.
In this summary of data a chemical was considered to have a posi-
tive effect if there was a mutagenic response over three concen-
trations and if the highest increase was, at the minimum, equal
to twice the solvent control for either TA98 and TAI00.
Original testing of methylenedianiline (MDA) indicated that all
steric isomers required S-9 activation for positive response of
the Ames strains. This held true with all other dianiline com-
pounds tested except for 4,4'-dimethyl-3,3'-methylenedianiline,
which caused a mutagenic response in TA1535 without S-9 microsomal
activation factors added to the test systems. For this reason,
only data from experiments where S-9 activation were used are
presented. These initial experiments also indicated that the most
responsive tester strains to these compounds were TA98 and TAI00,
representing tester strains which detect base pair (TAI00) and
frameshift (TA98) types of mutations. However, one MDA isomer
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(m,m') illustrates an anomalous case in which TA1537 and TA1538
responded very strongly to this compound whereas TAI00 and TA98
gave only marginal response.
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RESULTS
Relative Mutagenicity of Steric Isomers
Table III summarizes the relative microbial mutagenicities among
steric isomers of a series of five dianiline compounds differing
only in ring-coupling moieties. This includes DABiP with no con-
necting moiety. Figures 1-9 are graphs of the mean of three
replicate plates versus the dose per plate of test compounds using
TA98 and TAI00 tester strains. All six steric isomers were avail-
able for two of the dianiline series, MDA and DABP. Table III
provides information concerning the mutagenicity testing data of
each material. This table includes results from tests with the
two tester strains TA98 and TAI00. The relative mutagenic re-
sponse was determined by the minimum effective dose (MED) which
is defined as the lowest dose tested that results in revertants
per plate that are twice the value (minimum) of the revertants
per plate of the corresponding solvent controls. If the MED was
less than 0.05 mg/plate, the mutagenic response was reported as
"high." The mutagenic response was reported as "moderate" if the
MED was between 0.05 and 0.5 mg per plate and "low" if the MED
was greater than 0.5 mg per plate. The mutagenic response was
reported as "not detected" if the number of revertants did not
exceed two times the mean of the solvent controls at or below the
highest dose tested.
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The relative mutagenicity of the test materials can be observed
from these data. The o,m', o,p', and m,m' isomers of both MDA
and DABP demonstrated mutagenicity but the o,o' and m,p' isomers
of MDA and DABP exhibited no mutagenic response. The p,p' isomer
of MDA resulted in moderate mutagenicity, and no mutagenicity was
found for the p,p' isomer of DABP. These data indicate that the
steric positions of the amine groups in both the MDA and DABP
series affected the mutagenicity of the isomers.
Effects of Coupling Moieties
Some similarities in relative mutagenic responses can be noted
among isomers of different compounds (Table Ill). The o,m', o,p'
and m,m' isomers all demonstrated mutagenicity in one or both
strains for all compounds tested. The o,o' and m,p' isomers
demonstrated no mutagenic response for all compounds, with the
one exception of a moderate response to m,p' ODA in strain TA98.
The test results with the p,p' isomer varied from no detectable
mutagenic response to high mutagenicity depending the coupling
moiety.
The intensity of mutagenicity changed relative to the coupling
moieties. For example, ODA with the ether coupling moiety (-O-)
had the greatest overall mutagenicity among the aromatic diamines
tested. Every isomer of this compound tested demonstrated muta-
genicity in one or both strains. This was the only compound
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whose m,p' isomer demonstrated a mutagenic response. The DDS
compound with the sulfone coupling moiety (-SO 2 ) demonstrated the
least overall mutagenicity among the compounds tested.
3,5-DABP was also tested and found to have no detectable mutagen-
icity by the criteria stated earlier.
Effects of Proximity of Anilino Groups
The effects of linear separation of the -NH 2 groups in meta posi-
tions were evaluated (Table IV and Figure i0). Analogs of two-,
three- and four-ring compounds of m,m'-MDA were synthesized and
tested for relative microbial mutagenicity. The m,m'-MDA isomer
indicated a moderate mutagenicity among the tester strains. The
ml,m2-terbenzyl and m,m4-quaterbenzyl benzylogs gave no detect-
able response in all strains. The linear separation of the anilino
groups appears to "quench" the mutagenic effect of the amine groups
in these compounds.
Effects of Methyl and Other Moieties on Microbial Mutagenicity
Five methylated MDA and one methylated DABP isomer were tested.
The results are shown in Table V and Figures Ii and 12. In all
cases but one, 2,2'-dimethyl-5,5'-MDA, the mutagenicity of the
methylated isomers increased over the corresponding nonmethylated
isomers. The exceptional isomer gave approximately the same
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response as the nonmethylated m,m'-MDA isomer. The two methyl-
ated analogs of the p,p'-MDA isomer produced several fold more
revertants than the nonmethylated isomers when tested with TA98
and TAI00 strains.
In a previous study, it was found that the insertion of two iso-
propyl groups placed adjacent to the amino groups in both anilino
moieties rendered the p,p'-MDA isomer nonmutagenic. In contrast,
the insertion of chlorine atoms in each ring, as in dichlorodiani-
line (MOCA), greatly enhanced the mutagenicity of this same steric
isomer of MDA (Gridley and Ross, unpublished).
Effects of Sample Aging and Storage on Mutagenicit_ of m,p'-MDA
A sample of m,p'-MDA was tested for mutagenicity in 1977 and was
found to be nonmutagenic with TA98 (see Table VI and Figures 13
and 14). This same sample, retested in 1979, was found to have
moderate mutagenicity. No special care had been taken to protect
this sample from air or light and a discoloration was noted prior
to the retest. Another sample, Fresh-1979, of this isomer was
submitted for testing in 1979 and produced very low numbers of
revertants. Another sample, designated Fresh-81-7-2-473, was
tested and found to have high mutagenicity. This sample was
analyzed by high pressure liquid chromatography and found to con-
tain impurities. Further purification provided a sample, F2,
with much reduced impurity peaks and concomitant reduction in
mutagenicity.
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Because of this background information, a deliberate aging study
was performed with the m,p' MDA isomer. A purified sample was
divided into three aliquots. Sample A was aged two months in
nitrogen at ambient temperatures. Sample B was aged for two
months in air at ambient temperatures. Sample C was aged in air
at 50°C. These samples were then tested for mutagenicity with
TA98 and TAI00 tester strains. The resulting data are shown in
Table VII and in Figure 15. Low to no detectable mutagenicity
was found and no differences between samples were noted. The
aging times was apparently too short for sample degradation to be
expressed.
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CONCLUSIONS
The relative location of amine groups within the same diani-
line compound affects mutagenicity, in some cases considerably.
• The chemical nature of the connecting moieties between anilino
rings lead to considerable differences between the mutagen-
icity levels of the various compounds in this study.
Mutagenic intensity was found to be inversely proportional
to the distance between amino groups in benzylogs of
m,m'-MDA.
• Methyl groups intensified the mutagenicity of five of the
six isomers tested, with respect to the base nonmethylated
dianilino compound.
Sample storage methods may affect the mutagenicity of MDA
compounds.
The mutagenicity of m,p' MDA increased when the sample was
stored for long periods of time; i.e., 2 years. However,
changes were insignificant over shorter periods of times;
i.e., 2 months.
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Figure i. Reversion of Salmonella typhimurium
strain TA98 by MDA steric isomers.
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Figure 3. Reversion of Salmonella typhimurium
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TA98 by ODA steric isomers.
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TABLE IV. Summary of Ames Mutagenicity Data for MDA Benzylogs
Strain
Isomer TA98 TAI00
ml,m3-Terbenzyl-p 2
ml,m4-Terbenzyl-pz,p 3
m,m' MDA
a
ND I0 mg
ND 0.2 mg
Moderate b
ND i0 mg
ND 0.2 mg
Moderate b
al0 mg - mutagenicity not detected at i0 mg or less.
bDid not test below 0.5 mg.
TABLE V. Summary of Ames Mutagenicity Data
for Methylated Compounds
Strain
Isomer TA98 TAI00
4,4'-DM-3,3'-MDA
3,3'-DM-4,4'-MDA
4-M-3,4'-MDA
2,2'-DM-5,5'-MDA
2,2'-DM-4,4'-MDA
4-M-3,4'-DABP
High High
High High
ND _5 mg a Moderate
Low Low
Moderate Moderate
Low Low
a_5 mg - mutagenicity not detected at
5 mg/plate.
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TABLE VI. Summary of Ames Mutagenicity Data for Assessing Effects
of Aging and Storage on m,p' MDA - Long Term Study
Strain
Sample TA98 TAI00
A - Purified 1977, tested 1977
B - 1979 Sample tested 1979
C - Fresh sample (1979)
D - Fresh, 81-7-2-473
with impurities
E - F2,81-7-2-473 purified
ND a 1.0 mg
Moderate
ND 1.5 mg
Moderate
NT b
Moderate
ND 1.5 mg
Moderate
ND i0 mg Low
aNot detected.
bNot tested.
TABLE VII. Summary of Ames Mutagenicity Data for Assessing Effects
of Aging and Storage on m,p' MDA - Short Term Study
Strain
Sample TA98 TAI00
A - m,p' AI-aged in N 2
B - m,p' A,A,RT-aged in air at
room temperature
C - m,p' A,A,50-aged in air at
50oC
Low Low
ND a i0 mg Low
Low ND i0 mg
aNot detected.
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Mutagenicity of Dianiline Compounds
I. Introduction
This report is a discussion of the results of Ross, et al. (12)
presented in the report entitled "In vitro mutagenlc properties of
sterlc isomers of aromatic dlamlne compounds", hereafter referred to
as the Ross report. The aim of my work was to determine if common
structural features of aromatic dlamine isomers could be identified
in mutagenic compounds. The work consisted of a review of the Ross, et
al. data, a literature review and the writing of this report.
The aromatic amines constitute one of the largest families of
chemlcal structures that are known to be carcinogens. A significant
effort has been made to study the mutagenicity and potential carcino-
genicity of these compounds because of the known carcinogenicity of
some familiar aromatic amines and because of their wide use in commercial
applications, Some representative carcinogenic compounds that have been
studied in detail are 2-naphthylamine, 4-aminoblphenyl and 2-acetylamlno-
fluorene. The scientific llterature is extensive. Since a complete
review is beyond the scope of this report, the reader is referred to some
excellent reviews of the carcinogenicity of aromatic amines (1,3,5,13,16).
In this class of compounds, the dianilines have received little attention.
One of the dianillne compounds used in the Ross study has been screened in
some limited animal experiments for carcinogenlclty. The 4,4'-methylene
dlanillne (o,o' MDA) isomer is toxic to rats and therefore cannot be fed
at the high levels required for testing. Carcinogeniclty results are
consequently ambiguous. MDA may not be a carcinogen(3). Two analogs,
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4, 4'-methylene-bls (2-chloroanlllne) and 4,4'-methylene-bls(2-methylanillne),
are carcinogenic when the high levels are used (3). The best studied
carcinogenic dlanillne is benzldlne (diamlnoblphenyl), which, although
known to be a carcinogen for several years, has Just begun to receive
detailed attention (I,10,11,18; for an excellent review of benzldlne studies
to 1975, see the review by T. J. Haley, ref. 4). The similarity in
structure of benzldlne to the dlanilines studied here permits these
studies to serve as models for future research into the carclnogenicity
of the aromatic amines studied in the Ross report.
II. Analysis of Results
A. Previous studies using other aromatic amines that serve as model studies.
while some generalities determined in previous studies of aromatic
amines are applicable to the present one, the studies most pertinent are
those with benzldlne. All aromatic amines, including benzidlne, require
metabolic activation to be mutagens. It is therefore not surprising
that all dianilines in the Ross report that are mutagenic require incubation
in an activation system to acquire this activity. This aspect will be
discussed further in a later section. While benzidine is the most thoroughly
studied related compound, studies with it are limited. In my literature
review I found no studies with isomers of benzidlne comparable in extent
to the Ross study. Some studies address the question of mutagenic
activity when ring substitutions are made. For example, 2-methylbenzidtne
is a more potent carcinogen than benzidine (1). In contrast, benztdine
is a carcinogen add mutagen (8) while 3,3',5,5'-tetramethyl benztdine is
inactive as a carcinogen and mutagen (1). Further comparisons of ring
substitutions are reported in the review by Ashby (1) and the review by
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Selkirk (13). A significant conclusion of results with benzidine and
its derivatives is that no generalities with predictive value concerning
mutagenic activity can be made.
B. Relation between chemical structure and carcinogen/mutagen activity.
1) Generalities
Ideally, one would like to identify potential carcinogens based on
a knowledge of chemical structure. Many attempts at this kind of
correlation have been made, with the most useful and extensive studies
done with the polycyclic aromatic hydrocarbons (9,14; for reviews of this
area, see re,. 1,13,16). With respect to the Ross report, some significant
generalities based on literature reports can be made. These are: (I) the
structure-activity pattern observed for one series of carcinogens does
not apply to other series of carcinogens; (2) an unpredictability of
activity for isomers of the same or related compounds exists; (3) an
understanding of the activity relations between isomers will come about only
after consideration of the metabolic transformations of the isomers (5,9,17).
Too many exceptions to "predictability" exist in the literature to permit
dependable correlations, without knowledge of the structure of the
ultimate carcinogens in isomeric series, hypotheses relating structure to
activity are too much conjecture.
2) Specifics with reference to the Ross report.
The use of Salmonella strains that are reverted by different pathways,
either by a frameshift mutation (TA98) or a base substitution (TAt00),
permits the detection of different chemical mutagenesis pathways.
Unfortunately, little or no differential mutagenesis is obvious for the
various isomers (Table 3). One example of a type of difference searched
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for can be seen in Fig. 5 for ODA. The (m,m') isomer is classed iu
Table 3 as a moderate mutagen for strain TA98 and a low mutagen for TA100,
consistent with the definitions of these terms. Howeverj a look at the
actual data in Fig. 5 shows that the (m,m t) isomer, at higher concentrations,
is highly mutagenic in the TA98 strain and low in the TA100 strain. This
suggests that the activated ODA isomer is transformed to an ultimate
mutagen that acts preferentially by way of frameshifts. Can similar
differences be detected for related isomers? A pattern of this kind would
be evidence that different isomers are activated by similar pathways.
No patterns are obvious.
It is my opinion that it is too premature to search for structure-
activity relations in the sets of aromatic amines studied in the Ross
report. The requirement for metabolic activation for those isomers
that test positive as mutagens means that the ultimate mutagens are
unidentified and therefore have unknown structures. One might hope
that structure-activity relations would appear because of common
metabolic pathways, but no correlations are obvious. For example, the
(o,m') isomer of MDA is highly mutagenlc whereas the (o,m') isomer of
two other compounds (DABP and DDS) are not. One can conjecture on the
influence of the various groups on the electronic nature of the reactive
groups but no consistent hypothesis is readily forthcoming.
C. The requirement for activation
All aromatic amines including the dianilines studied in the Ross
report require metabolic activation for mutagenlc activity. Structure-
activity relations may become more obvious when detailed studies of
metabolic pathways are completed. Activation systems are complex and
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undefined. This complexity precludes the assumption of common metabolic
pathways. However, considerable progress in this area has been made
and several sophisticated studies can serve to offer direction in this
area ( for reviews, see 2,5,6,16,17).
Some generalities for activation of aromatic amines exist. For
example, a common step for carcinogenic and mutagenlc activation is
N-hydroxylatlon. The ultimate carcinogen may be caused by the
esterlfication of the N-hydroxy group (1,5,17). It has been shown in
some cases that the ester derivatives bind to macromolecules such as DNA
and protein. Evidently the ester derivatives are electrophillc reactants
capable of binding to nucleophilic centers in DNA. For example, the well-
studied aromatic amine 2-acetylamlnofluorene (AAF) is converted initially
to the procarclnogen N-hydroxy-AAF, which is further metabolized to the
acetate of N-hydroxy-AAF by esterlflcatlon of hydroxamlc acid to give the
ultlmate carcinogen N-acetoxy-AAF. This compound has a direct action on
DNA that may be responsible for its mutagenlc and carcinogenic activities (5).
These generalities seem to hold true for benzldine. N-acetylated
benzldlne derivatives that are mutagenlc are found in the urine of rats
treated with benzldlne (15). Benzldlne can be converted in a liver extract
to an N-hydroxy compound (N-hydroxy-N, Nt-dlacetyl-benzldlne) which binds
to DNA and is a direct mutagen (10). In addition, the N-hydroxy compound
can be esterlfled to an N-acetoxy dlacetylbenzldine which is proposed as
the ultimate carcinogen (11). Other evidence that benzldine metabolites
bind to DNA has been presented (18). These results are important as
they show that the generalities for structure-activity relations
detected for other aromatic amines seem to hold true for benzidine.
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This suggests that activation of the dianilines may follow similar routes.
III. Conclusions
The results presented in the Ross report show that some of the
steric isomers of sets of aromatic diamtne compounds are mutagenic when
treated with metabolic activation systems. Results of others suggest
that the Salmonella/mutagenic assay conducted as described in the Ross
report is a good predictive indicator of carcinogenesis (2,8). Negative
results employing a single metabolic activation system do not imply that
that isomer is not a mutagen. Further mutagenesis assays employing other
activation systems or conditions are required.
It is suggested that one cannot predict the mutagenicity of an
isomer based on its structure at this time. The ability to make this
kind of prediction Is an ultimate desirable goal. Several well documented
reviews describe attempts of others directed toward the same goal. The
goal is an achievable one but will require a significantly greater amount
of information, primarily with respect to chemical transformation caused
by metabolic systems.
A study of metabolic activation can lead to knowledge concerning
relations between chemical structure and activity. Existing data shows
that some common steps occur in the actlvatlon of aromatic amines to both
pro and ultimate carcinogens. Further studies directed with this goal In
mlnd can contribute to the eventual understanding of chemical structure
and carcinogenic potential.
The Ross study is unique in that five different sets of dianiline
compounds, four of which are represented by nearly all of the possible
B-8
sterlc isomers, were tested. To my knowledge no slmilar studies for
the complete set of benzldlne isomers or other aromatic amines have been
reported.
IV. Further research
The Ross study leads to several suggestions for future research.
I suggest that the most important is to concentrate on the complete
set of MDA isomers and study their metabolic activation. Initially, one
should work with the most mutagenic isomer, (o,mt). The pro and ultimate
mutagens can be followed through fractionation of the activation mix by
biological activity. One could acquire radio-labeled isomers and
follow metabolic derivatives by radio-tracer methods. One can specifically
search for N-hydroxylation products and N-acetoxy products. A similar
survey of the remaining isomers should provide the necessary information
for establishing structure-activity relations. The relations should
provide useful information for an understanding of the activity of the
other dianilines and for structure-activity predictions.
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APPENDIX C
ACUTE CYTOTOXICITY CLONAL ASSAY DATA
/
!

CYTOTOXICITY DATA FOR m,m' DABP
CELL LINE: CHO-KI
CONTROL
(BACKGROUND)
VALUES
444
397
463
448
416
CONCENTRATION
(G/ML)
REPLICATE
VALUES
MEAN
VALUE
434
?kG_. 15
C_,,G_P,LQUALITY
p_.p_oo_
9-14-82
PAGE REF: -
MEAN
VALUE
STANDARD
DEVIATION
STANDARD
DEVIATION
27
PERCENT
SURVIVAL
/
.0003
,0001
°00005
,00001
,000005
°000001
5,00000E-07
BASIC
>
0
0
0
307
295
32B
440
437
424
428
416
411
434
484
476
427
422
441
442
443
433
0
310
434
418
465
430
439
17
9
27
10
71
100
100
100
100
100
C-2
/

\\,
.°
CYTOTOXICITY DATA FOR m,a' DABP
CELL LINE: D98S
/
ORI_NAL PAGE I_
OF POOR _,,_''TY 9-14-82
PAGE REF: -
CONTROL
(BACKGROUND)
VALUES
413
424
472
406
413
CONCENTRATION
(G/HL)
REPLICATE
VALUES
.MEAN
VALUE
426
MEAN
VALUE
STANDARD
DEVIATION
STANDARD
DEVIATION
27
PERCENT
SURVIVAl
/
.0003
.0001
.00005
.00001
.000005
.000001
5.00000E-07
BASIC
>
0
0
0
224
265
228
356
398
372
433
472
447
479
496
495
484
467
483
497
499
499
239
375
451
490
478
498
0
23
21
20
10
10
1
56
88
100
100
100
100
C_ 3 "
/

CYTOTOXICITY DATA FOR o,P' DABP-
CELL LINE= CHO-KI
ORI_NAL PAGE IS
OF POOR QUALITY
9-14-82
PAGE REF= -
CONTROL
_DACKGROUND)
VALUES
444
397
463
448
416
MEAN
VALUE
434
STANDARD
DEVIATION
27
CONCENTRATION
(G/HL)
REPLICATE
VALUES
MEAN
VALUE
STANDARD
DEVIATION
PERCENT
SURVIVA
/
.0003
o0001
°00005
.00001
°000005
°000001
5.00000E-07
BASIC
>.
0
0
0
163
148
141
373
349
380
420
427
415
450
445
466
346
435
435
421
429
400
0
151
367
421
454
405
417
11
16
6
11
51
15
35
85
100
100
100
100
C-4

CYTOTOXICITY DATA FOR o,P" DABP
CELL LINE! DgBs
CONTROL
(BACKGROUND)
VALUES
413
424
472
406
413
Of _u,-,'-
MEAN
VALUE
426
9-14-82
PAGE REF:
STANDARD
DEVIATION
27
/
CONCENTRATION
(G/NL)
.0003
,0001
.00005
,00001
.000005
,000001
5.00000E-07
BASIC
REPLICATE
VALUES
0
0
0
0
0
0
81
83
80
470
421
483
495
482
490
429
426
486
484
506
471
MEAN
VALUE
81
458
489
447
407
STANDARD
DEVIATION
0
0
2
33
7
34
18
PERCEN'
SURVIV,
0
19
100
100
C-5
/

CYTOTOXICITY DATA FOR o,o DABP
CELL LINE; CHO-L1
i
Ft?_IIVAL
9-14-e2 "":-.. vu,4L/ry
PAGE REF ; -
CONTROL
(BACKGROUND)
VALUES
444
397
463
449
416
MEAN
VALUE
434
STANDARD
DEVIATION
27
CONCENTRATION
(G/HL)
REPLICATE
VALUES
MEAN STANDARD PERCENT
VALUE DEVIATION SURVIVAt
/
.0003
.0001
.00005
.00001
.000005
.000001
5.00000E-07
BASIC
0
0
0
21
17
20
352
374
339
451
431
447
416
447
404
427
410
419
462
449
415
0 0 0
19 2 4
355 18 82
443 11 100
422 22 100
419 9 100
442 24 100
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CYTOTOXICITY DATA FOR opo'
CELL LINE: Dgss
ORiGiNAL
OF pOOR
DABP 9-14-82
PAGE REF: -
CONTROL
(BACKGROUND)
VALUES
413
424
472
406
413
MEAN
VALUE
426
STANDARD
DEVIATION
27
CONCENTRATION
(G/HL)
REPLICATE
VALUES
MEAN
VALUE
STANDARD
DEVIATION
PERCENT
SURVIVAL
/
.0003
.0001
.00005
.00001
,000005
.000001
5,00000E-07
0
0
0
0
0
0
301
320
262
478
457
440
479
477
484
478
485
512
443
478
456
0
0
294
458
480
492
459
0
3O
19
4
18
18
0
69
I00
100
100
100
C-7

CYTOTOXICITY DATA FOR PtP'-DABP
CELL LINE: CHO-K1
ORIGINAC PA3_ F_
OF POOR QUALITY
11-15-82
PAGE REF; -
CONTROL
(BACEGROUND)
VALUES
564
515
56B
516
MEAN
VALUE
54I
STANDARD
DEVIATION
29
CONCENTRATION
(GIML)
REF'LICATE
VALUES
MEAN
VALUE
STANDARD
DEVIATION
PERCENT
SURVIVAL
/
.0003
.0001
.00007
.00004
°00001
,000005
BASIC
>
.."
405
485
4BO
619
605
624
595
586
588
515
520
524
512
553
577
457
616
590
520
,547
0
45
10
5
5
33
84
100
100
100
100
C-8
/

CYTOTOXICITY DATA FOR P,P'-DABP
CELL LINE: IegB5
'_rNAL
POoR _
VU_LIT_
11-15-82
PAGE REF: -
CONTROL
(BACI_GROUND)
VALUES
454
489
463
466
452
MEAN
VALUE
465
STANDARD
DEVIATION
15
CONCENTRATION
(G/ML)
REPLICATE
VALUES
MEAN
VALUE
STANDARD
DEVIATION
PERCENT
SURVIVAL
/
,0003
.0001
.00007
,00004
.00001
,000005
BASIC
>
0
0
0
0
0
0
94
39
127
446
429
467
456
444
476
455
479
458
0
87
447
459
464
44
19
16
13
29
100
100
100
c-g
/
/

CYTOTOXICITY DATA FOR m_P'-DABP
CELL LINE_ CHO-K1
CONTROL
(BACKGkOUND)
VALUES
564
515
56B
516
CONCENTRATION
(O/ML)
REPLICATE
VALUES
.0003
o0001
.00007
.00004
.00001
°000005
BASIC
>_
• b
o.
0
0
0
583
517
506
a22
656
614
601
619
634
583
562
573
609
60B
574
MEAN
VALUE
541
MEAN
VALUE
535
63I
618
573
597
11-15-82
PAGE REF= D
o_IG_L p_GE 15
oF poOR QuALiTY
STANDARD •
IoEVIATION
0
42
22
17
11
2O
STANDARD
DEVIATION
29
PERCENT
SURVIVAL
0
100
100
100
lO0
100
C-lO
/
/

CYTOTOXICZTY DATA FOR JJeP'-DABP
CELL LINE: D98S
ORIGINAL PAGE IS
OF POOR QLIALITY
11-15-82
PAGE REF: -
CONTROL
(_AChGROUND)
VALUES
4,54
499
463
466
452
MEAN
VALUE
_wa_u
465
STANDARD
DEVIATION
15
CONCENTRATION
(G/ML)
REPLICATE
VALUES
MEAN
VALUE
STANDARD
DEVIATION
PERCENT
SURVIVAL
.0003
.0001
.00007
.00004
,00001
.000005
0
0
0
235
268
254
353
396
409
476
455
450
477
491
469
450
438
484
0
252
386
460
479
457
0
17
29
14
11
24
0
54
83
100
I00
100
C-11

\CYTOTOXICITY [IATA FOR oFJ,'-DABP
CELL LINE: CHO-_I
CONTROL
(BACKGROUND)
VALUES
564
515
568
MEAN
VALUE
541
11-15-B2
PAGE REF! -
G_ _STAN[IARD
_EVlATZON
29
CONCENTRATION
(G/ML)
REPLICATE
VALUES
MEAN STANDARD F'ERCENT
VALUE DEVIATION SURVIVAL
/
.0003
.o001
.00007
.00004
.00001
.000005
BASIC
>
0
0
0
323
311
329
430
416
422
582
583
590
585
601
592
605
561
53e
0 0 0
321 9 59
423 7 78
585 4 100
593 8 I00
56B 34 100
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CYTOTOXZCZTYDATA FOR o,m'-DABP
CELL LINE: D985
11-15-82
PAGE REF: -
CONTROL
(BACKGROUN[f)
VALUES
4,54
4B9
463
466
452
HEAN
VALUE
465
STANDARD
DEVIATION
15
CONCENTRATION
(G/ML)
.0003
.0001
°00007
.00004
.00001
.000005
REPLICATE
VALUES
0
0
0
42
66
51
211
280
243
483
443
447
481
489
476
463
448
482
MEAN
VALUE
0
53
245
458
482
464
STANDARD
DEVIATION
0
12
3S
22
7
17
PERCENT
SURVIVAL
0
11
53
100
100
100
C-13

:YTDTDXICITY _ATA FOR [_MSO
ELL LINE: CHD-E]
CONTROL
BACKGROUND)
VALUES
564
515
568
5]6
OR_GfNAL PAGE IS
OF POOR QUALITY
MEAN
VALUE
_wmm
541
11-15-B2
P_OE REF_ -
STANDARIJ
DEVIATION
29
_ONCENTRATIDN
(UL/35 ML)
REPLICATE
VALUES
STANDAR_
DEVIATION
PERCENT
SURVIVAL
525
]75
607
599
670
5BB
666
687
634
657
616
661
37
22
100
100
C-14
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CYTOTOXICITY PATA FOR DMSO
CELL LINE: D985
i
Ofpa ....
f 1
11-15-82
PAGE REF :
Q •
CONTROL
(_ACKGROUND)
VALUES
454
489
463
466
4.%2
MEAN
VALUE
465
STANDARD
[IEUIATION
Z5
/
CONCENTRATION
(UL/35 NL)
,!
525 " "
175
REPLICATE
VALUES
480
471
4_7
518
476
490
444
4_5
MEAN
VALUE
482
466
STANDARD
DEUZATZON
26
21
PERCENT
SURU]UAL
100
100
C-15

